Undisplaced Femoral Neck Fractures 2 Hansson Pins or 3 Pins Interlocked in Plate (Pinloc) Using RSA

May 10, 2021 updated by: Frede Frihagen, Oslo University Hospital

Undisplaced Femoral Neck Fractures Treated With 2 Hansson Pins Without Plate or 3 Hansson Pins Interlocked in a Plate (Pinloc) - A Randomized Controlled Trial Using Radiostereometry

Femoral neck fractures represent about half of the hip fractures and are further divided into displaced and undisplaced fractures. Displaced femoral neck fractures are almost always treated surgically with arthroplasty. However there is an ongoing debate on which implant is superior for undisplaced fractures.

A novel implant design (Pinloc) has been developed by Swemac Innovation AB. While the original implant consisted of 2 isolated hook pins, the modified design consists of 3 titanium hook pins interlocked in an aluminum plate. Interlocking is a new principle of implant design and improves fixation and load transfer amongst the pins. The superiority of the modified design is so far only proven preclinically.

The role of the Pinloc in clinical use remains unclear. Investigators are planning a randomized controlled trial on undisplaced femoral neck fractures to establish a method for implanting the tantalum markers, to observe the fracture healing process and to further investigate the role of the Pinloc.

Study Overview

Status

Completed

Detailed Description

Femoral neck fractures represent about half of the hip fractures and are further divided into displaced and undisplaced fractures. Displaced femoral neck fractures are almost always treated surgically with arthroplasty. However there is an ongoing debate on which implant is superior for undisplaced fractures.

A novel implant design (Pinloc) has been developed by Swemac Innovation AB. While the original implant consisted of 2 isolated hook pins, the modified design consists of 3 titanium hook pins interlocked in an aluminum plate. Interlocking is a new principle of implant design and improves fixation and load transfer amongst the pins. The superiority of the modified design is so far only proven preclinically. The role of the Pinloc in clinical use remains unclear.

A series of studies is now planned at Oslo University Hospital in collaboration with Diakonhjemmet Hospital in hope to further clarify this debate. The use of the Pinloc has been introduced in some regions (e.g. Norway, Sweden and Japan). The role of the Pinloc remains unclear and very little has been published on it's use, even though it is believed to be an important contributor of stability to the fixation.

Femoral neck fractures are mainly caused by a fall from own height in the elderly. The fractures are most often classified as displaced or not, using the simplified Garden classification. Several other classification systems also exist, but these have not been shown to be of reliable clinical usefulness. The ideal classification system should be easily applicable, reliable, and aid in treatment decision making and prognosis.

The treatment of femoral neck fractures comprise perioperative and operative modalities. The perioperative modalities consist among others of medical optimalization preoperatively, early rehabilitation and prevention of new fractures by treating osteoporosis and preventing new falls. The main scope of the current study will, however, be the operative modalities.

Surgery for undsiplaced femoral neck fractures is performed mainly with internal fixation on a traction table, using either screws, pins or a sliding hip screw (SHS), available in various designs from different manufacturers. The latest Cochrane review did not conclude on which implant is the superior.

Radiostereometry (RSA) is the most precise and accurate method to measure motion in vivo between different segments in orthopaedic research. To do so, radioopaque tantalum markers are implanted into the bone defining different segments. Stereoradiographs are performed over time to detect movement and monitor the healing (or non healing) process. This movement can be calculated both as translations and rotations. They are ideal to describe and compare the stability of fracture systems. RSA has been used successfully in earlier studies on fracture healing. Due to the high accuracy and precision, RSA yield reliable results with relatively small study-groups. Investigators plan to use RSA to measure fracture dislocation and time to healing in our studies. The study will be on the function of the Pinloc and it´s ability to prevent secondary dislocation in undisplaced femoral neck fractures. Investigators will utilize RSA for measurements during follow-up.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0408
        • Orthopedic Center, Ulleval University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • undisplaced femoral neck fractures
  • able to walk independently, aids such as crutches or walker allowed
  • able to consent
  • fit for surgery with pins with or without plate

Exclusion Criteria:

  • not willing or able to attain follow up
  • previous fracture or surgery with retained metal work in the same hip
  • concomitant disease that will shorten life expectancy (i.e. cancer, COPD)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 2 Hansson pins without plate
Patients with undisplaced femoral neck fractures operated with 2 isolated Hansson pins.
2 isolated hook pins.(Without plate)
Other Names:
  • 2 isolated hook pins.
Active Comparator: 3 Hansson pins interlocked in a plate
Patients with undisplaced femoral neck fractures operated with 3 Hansson pins interlocked in plate (Pinloc).
3 hook pins interlocked in plate.
Other Names:
  • 3 hook pins interlocked in plate.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in fracture displacement during healing measured with radiostereometry
Time Frame: Up to 52 weeks
Will be measured by RSA postoperatively, before discharge and after 4, 8, 12, 24 and 52 weeks. Total displacement from first reading to the reading showing maximum displacement is the main outcome.
Up to 52 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perioperative blood loss
Time Frame: 1 week
1 week
Time of surgery
Time Frame: 1 week
1 week
Eq5d
Time Frame: 52 weeks
Health Related Quality of Life (Hrqol).
52 weeks
Eq5d
Time Frame: 26 weeks
Hrqol.
26 weeks
Eq5d
Time Frame: 12 weeks
Hrqol.
12 weeks
Eq5d
Time Frame: 4 weeks
Hrqol.
4 weeks
Postoperative pain (NRS) while in hospital
Time Frame: 1 week
Pain at mobilization (NRS) at discharge
1 week
Pain (NRS)
Time Frame: 4 weeks
Maximum hip pain during the last week
4 weeks
Pain (NRS)
Time Frame: 12 weeks
Maximum hip pain during the last week
12 weeks
Pain (NRS)
Time Frame: 26 weeks
Maximum hip pain during the last week
26 weeks
Pain (NRS)
Time Frame: 52 weeks
Maximum hip pain during the last week
52 weeks
Reoperation for healing problems
Time Frame: 52 weeks
Any additional surgery addressing healing problems or hardware failure
52 weeks
Mortality
Time Frame: 52 weeks
Any reason
52 weeks
Change in time to union as measured by RSA (cessation of motion) and radiographs
Time Frame: Will be examined at 4, 12, 26 and 52 weeks
When RSA shows that no motion has happened between two time points the fracture will be regarded as healed at the former time point.
Will be examined at 4, 12, 26 and 52 weeks
Change in time to union as measured by plain radiographs and clinical findings
Time Frame: Will be examined at 4,12, 26 and 52 weeks
Composite endpoint: Healing defined by obliteration of fracture line radiographically and pain free weight bearing (except lateral pain from hardware), when this occurs the fracture will be considered healed.
Will be examined at 4,12, 26 and 52 weeks
Harris Hip Score
Time Frame: Up to 52 weeks
Will be examined at 4,12, 26 and 52 weeks
Up to 52 weeks
Timed Up and Go test
Time Frame: 4 weeks
Tug
4 weeks
Timed Up and Go test
Time Frame: 12 weeks
Tug
12 weeks
Timed Up and Go test
Time Frame: 26 weeks
Tug
26 weeks
Timed Up and Go test
Time Frame: 52 weeks
Tug
52 weeks
Satisfaction with operated hip (NRS)
Time Frame: 4 weeks
NRS
4 weeks
Satisfaction with operated hip (NRS)
Time Frame: 12 weeks
NRS
12 weeks
Satisfaction with operated hip (NRS)
Time Frame: 26 weeks
NRS
26 weeks
Satisfaction with operated hip (NRS)
Time Frame: 52 weeks
NRS
52 weeks
Motion during healing as measured by radiostereometry.
Time Frame: Up to 52 weeks
Will be measured by RSA postoperatively, before discharge and after 4, 12, 24 and 52 weeks.
Up to 52 weeks
Motion during healing as measured by plain radiographs.
Time Frame: Up to 52 weeks
Will be measured by RSA postoperatively, before discharge and after 4,12, 24 and 52 weeks.
Up to 52 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Frede Frihagen, PhD, Oslo UH

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2016

Primary Completion (Actual)

April 1, 2021

Study Completion (Actual)

May 1, 2021

Study Registration Dates

First Submitted

January 20, 2016

First Submitted That Met QC Criteria

March 3, 2016

First Posted (Estimate)

March 4, 2016

Study Record Updates

Last Update Posted (Actual)

May 11, 2021

Last Update Submitted That Met QC Criteria

May 10, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2015/191/REK SO B

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

International peer review journal

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on 2 Hansson pins

Subscribe